Post by Kyinno Biotechnology, Inc.

CCR chemokine receptors have become key targets in immunology and oncology, playing critical roles in immune cell trafficking, tissue homing, and tumor microenvironment remodeling. As interest in CCR-targeted therapies continues to grow, reliable in vitro models are essential for accelerating drug discovery and translational research. Kyinno Biotechnology, Inc.'s comprehensive CCR1-CCR10 Engineered Cell Portfolio supports every stage of development, from ligand binding and receptor internalization studies to agonist/antagonist functional assays, cross-reactivity evaluation, and quality control testing. Available across multiple host cell backgrounds and species variants, these engineered cell models help researchers generate standardized, reproducible data for GPCR-targeted therapeutic development. For more information, contact #Kyinno or visit https://www.kyinno.com/ #CCR #GPCR #Immunotherapy #CancerResearch #DrugDiscovery #CellLineModels #Biotechnology #Immunology #TumorMicroenvironment #Kyinno